He also gave an update on stem cell therapy clinical trials during Retina Subspecialty Day. Ho, program co-chair for Eyecelerator, moderated a presentation on the future of age-related macular degeneration treatments and technology in front of an audience attendance of 1,000+. Regillo, and several retina fellows presented educational cases.ĭr. From our team, Allen Ho, MD, Jose Pulido, MD, Dr. Wills Eye Hospital held “Meet the Experts” sessions. He also led a panel discussion on pediatric retinal diseases during Retina Subspecialty Day. Yonekawa devised a “fear meter” in which retinal findings with signs of disease are prioritized over systemic conditions that have retinal findings. Yoshihiro Yonekawa, MD presented on pediatric retinal conditions and their urgency during Pediatric Subspeciality Day.
Regillo played key roles in developing this treatment modality. The three year follow up data from the Archway study showed positive safety and efficacy results in patients who underwent follow up treatment. The Annual American Academy of Ophthalmology (AAO) Conference was held in Chicago from September 30 to October 3 and many of our Mid Atlantic Retina doctors were invited to give lectures, moderate panels, and lead instructional courses, as leaders in the retina community.Ĭarl Regillo, MD presented an update on the Susvimo Port Delivery system for age-related macular degeneration during Retina Subspecialty Day.
0 kommentar(er)
